Dietary supplementation of silymarin protects against chemically induced nephrotoxicity, inflammation and renal tumor promotion response
- 10 July 2009
- journal article
- Published by Springer Nature in Investigational New Drugs
- Vol. 28 (5) , 703-713
Abstract
Ferric nitrilotriacetate (Fe-NTA) is a potent nephrotoxicant and a renal carcinogen that induces its effect by causing oxidative stress. The present study was undertaken to explore protective effect of silymarin, a flavonolignan from milk thistle (Silybum marianum), against Fe-NTA mediated renal oxidative stress, inflammation and tumor promotion response along with elucidation of the implicated mechanism(s). Administration of Fe-NTA (10 mg/kg bd wt, i.p.) to Swiss albino mice induced marked oxidative stress in kidney, evident from augmentation in renal metallothionein (MT) expression, depletion of glutathione content and activities of antioxidant and phase II metabolizing enzymes, and enhancement in production of aldehyde products such as 4-hydroxy-2-nonenal. Fe-NTA also significantly activated nuclear factor kappa B (NFκB) and upregulated the expression of downstream genes: cyclooxygenase 2 and inducible nitric oxide synthase and enhancing the production of proinflammatory cytokines: tumor necrosis factor alpha (TNF-α) and interleukin-6 (IL-6). However, feeding of 0.5% and 1% silymarin diet conferred a significant protection against Fe-NTA induced oxidative stress and inflammation. It further augmented MT expression, restored the antioxidant armory, ameliorated NFκB activation and decreased the expression of proinflammatory mediators. Silymarin also suppressed Fe-NTA induced hyperproliferation in kidney, ameliorating renal ornithine decarboxylase activity and DNA synthesis. From these results, it could be concluded that silymarin markedly protects against chemically induced renal cancer and acts plausibly by virtue of its antioxidant, anti-inflammatory and antiproliferative activities.Keywords
This publication has 44 references indexed in Scilit:
- Multitargeted therapy of cancer by silymarinCancer Letters, 2008
- Coordinated induction of Nrf2 target genes protects against iron nitrilotriacetate (FeNTA)-induced nephrotoxicityToxicology and Applied Pharmacology, 2008
- NF-κB in carcinoma therapy and preventionExpert Opinion on Therapeutic Targets, 2008
- Inhibition of T-Cell Inflammatory Cytokines, Hepatocyte NF-κB Signaling, and HCV Infection by Standardized SilymarinGastroenterology, 2007
- Cyclooxygenase-2: How good is it as a target for cancer chemoprevention?European Journal of Cancer, 2005
- Formation of Acrolein-derived 2′-Deoxyadenosine Adduct in an Iron-induced Carcinogenesis ModelJournal of Biological Chemistry, 2003
- Effects of idoxifene and estradiol on NF‐κB activation in cultured rat hepatocytes undergoing oxidative stressLiver International, 2001
- Evidence that Fe‐NTA‐induced renal prostaglandin F2α is responsible for hyperplastic response in kidney: Implications for the role of cyclooxygenase‐dependent arachidonic acid metabolism in renal tumor promotionIUBMB Life, 1997
- Coordination of copperpolyamine complex with imidazoles potentiates its superoxide dismutase mimicking activity and abolishes its interaction with albuminIUBMB Life, 1996
- Ferric Nitrilotriacetate (Fe-NTA) Is a Potent Hepatic Tumor Promoter and Acts Through the Generation of Oxidative StressBiochemical and Biophysical Research Communications, 1995